PCK1 and cancer: mTORC2-dependent upregulation of PCK1 can be detrimental to cancer cell survival through the activation of gluconeogenesis41, whereas TP53-dependent downregulation of PCK1 may be relevant to tumor suppression in HEPG2 and HCT116 cells42.